Mortality in hemodialysis patients with COVID-19, the effect of paricalcitol or calcimimetics

Authors

María Dolores Arenas Jimenez, IMIM Hospital del Mar Medical Research Institute
Adriana S Dusso, Washington University School of Medicine in St. Louis
et al

Journal

Nutrients

Publication Date

2021

Volume

13

Issue

8

First Page

2559

Document Type

Open Access Publication

DOI

10.3390/nu13082559

Rights and Permissions

Arenas Jimenez MD, González-Parra E, Riera M, et al. Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics. Nutrients. 2021;13(8):2559. Published 2021 Jul 26. doi:10.3390/nu13082559

Recommended Citation

Arenas Jimenez, María Dolores; Dusso, Adriana S; and et al, "Mortality in hemodialysis patients with COVID-19, the effect of paricalcitol or calcimimetics." Nutrients. 13, 8. 2559 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10682